Published in Pharmacoeconomics on January 01, 2010
The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation. Diabetes Technol Ther (2015) 1.40
Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectiveness. Diabetes Care (2013) 1.15
Towards renewed health economic simulation of type 2 diabetes: risk equations for first and second cardiovascular events from Swedish register data. PLoS One (2013) 0.97
Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equations. PLoS One (2014) 0.81
Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation. Clinicoecon Outcomes Res (2012) 0.80
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes. BMJ Open (2013) 0.77
Costing of diabetes mellitus type II in Cambodia. Health Econ Rev (2014) 0.76
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
The impact of conservation on the status of the world's vertebrates. Science (2010) 6.71
Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med (2008) 4.28
Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA (2006) 3.83
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ (2011) 3.81
Cast versus splint in children with minimally angulated fractures of the distal radius: a randomized controlled trial. CMAJ (2010) 3.15
Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 2.69
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making (2002) 2.53
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
Disruption of tumor neovasculature by microbubble enhanced ultrasound: a potential new physical therapy of anti-angiogenesis. Ultrasound Med Biol (2011) 2.18
Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology (2009) 2.05
Paradise lost. J Ark Med Soc (2013) 2.03
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention (2009) 1.94
A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ (2003) 1.93
Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 1.92
Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain (2008) 1.76
The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med (2003) 1.72
Lessons learned from pilot site implementation of an ambulatory electronic health record. Proc (Bayl Univ Med Cent) (2006) 1.70
Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol (2005) 1.68
Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making (2011) 1.67
Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.66
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2008) 1.65
Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation (2005) 1.62
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review. Expert Rev Pharmacoecon Outcomes Res (2014) 1.58
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med (2005) 1.54
Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53
Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. Can J Ophthalmol (2010) 1.51
Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl (2006) 1.51
Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol (2009) 1.51
Surgical treatment of facial soft-tissue deformities in postburn patients: a proposed classification based on a retrospective study. Plast Reconstr Surg (2013) 1.46
Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly. Eur Heart J (2007) 1.44
Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J (2012) 1.44
The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. J Bone Joint Surg Am (2007) 1.42
Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol (2010) 1.41
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes (2008) 1.40
The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc (2011) 1.38
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm (2005) 1.38
A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up. Surg Innov (2006) 1.37
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health (2010) 1.32
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol (2005) 1.25
Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin (2007) 1.23
A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med (2013) 1.22
Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol (2004) 1.22
Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates. Can Fam Physician (2013) 1.21
Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.21
The economics of health information technology in medication management: a systematic review of economic evaluations. J Am Med Inform Assoc (2011) 1.20
A review of the cost of cardiovascular disease. Can J Cardiol (2009) 1.20
Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke (2004) 1.17
Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience. Int J Technol Assess Health Care (2007) 1.16
A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc (2011) 1.15
Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients. Circulation (2013) 1.15
Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial. Pediatrics (2006) 1.14
Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol (2009) 1.14
Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes (2010) 1.09
Microbubble cavitation imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 1.08
Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Qual Life Res (2008) 1.08
Common Drug Review recommendations: an evidence base for expectations? Pharmacoeconomics (2012) 1.08
Patient views on reminder letters for influenza vaccinations in an older primary care patient population: a mixed methods study. Can J Public Health (2008) 1.06
Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Prev Med (2008) 1.04
The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque. Cardiovasc Res (2006) 1.03
Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index. Value Health (2010) 1.00
Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol (2009) 1.00
Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod (2013) 1.00
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord (2011) 0.99
Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada. Value Health (2003) 0.99
Tissue expansion in the treatment of giant congenital melanocytic nevi of the upper extremity. Medicine (Baltimore) (2017) 0.97
Differences in definity and optison microbubble destruction rates at a similar mechanical index with different real-time perfusion systems. J Am Soc Echocardiogr (2003) 0.97
The use of microbubbles to target drug delivery. Cardiovasc Ultrasound (2004) 0.97
Effects of study design and trends for EVAR versus OSR. Vasc Health Risk Manag (2008) 0.97
Myocardial perfusion imaging with contrast ultrasound. JACC Cardiovasc Imaging (2010) 0.96
Simultaneous atmospheric nitrous oxide, methane and water vapor detection with a single continuous wave quantum cascade laser. Opt Express (2015) 0.96
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res (2012) 0.96
Incidence of cardiac arrhythmias with therapeutic versus diagnostic ultrasound and intravenous microbubbles. J Ultrasound Med (2005) 0.95
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res (2011) 0.95